Wuhan Keqian Biology Co.,Ltd (SHA:688526)

China flag China · Delayed Price · Currency is CNY
14.68
+0.15 (1.03%)
Apr 29, 2026, 3:00 PM CST
-6.97%
Market Cap 6.81B
Revenue (ttm) 949.74M
Net Income (ttm) 418.72M
Shares Out 463.92M
EPS (ttm) 0.90
PE Ratio 16.31
Forward PE 14.32
Dividend 0.64 (4.40%)
Ex-Dividend Date Jun 16, 2025
Volume 1,880,167
Average Volume 2,250,869
Open 14.55
Previous Close 14.53
Day's Range 14.48 - 14.71
52-Week Range 14.17 - 20.39
Beta 0.59
RSI 41.83
Earnings Date Apr 8, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 922
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688526
Full Company Profile

Financial Performance

In 2025, SHA:688526's revenue was 949.74 million, an increase of 0.83% compared to the previous year's 941.92 million. Earnings were 418.72 million, an increase of 9.51%.

Financial Statements

News

There is no news available yet.